series-c-plus
Stage
2
Investors
About
OptiNose develops specialty pharmaceutical products that utilize its proprietary Bi-Directional Exhalation Delivery System to deliver medication effectively to the ear, nose, and throat regions, primarily for ENT and allergy conditions.
Explore OptiNose's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.